Ignite Creation Date:
2025-12-24 @ 9:17 PM
Ignite Modification Date:
2025-12-29 @ 12:01 AM
Study NCT ID:
NCT00088504
Status:
COMPLETED
Last Update Posted:
2007-12-21
First Post:
2004-07-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VX03-497-205
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Robert Kauffman, M.D., Ph.D.
Old Organization:
Vertex Pharmaceuticals Incorporated